Clinical Trials on Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection in Korea, Democratic People's Republic of

Total 4 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Klebsiella Infections | Escherichia Coli Infections

Korea, Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Gram-Positive Bacterial Infections | Klebsiella Infections | Escherichia Coli Infections

Korea, Republic of
Samsung Medical Center

Completed

Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract

Recurrent Cystitis

Korea, Republic of
Janssen Research & Development, LLC

Recruiting

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

United States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Sweden, Czechia, Italy

3

Subscribe